NAV
$89.26
AUM
$30.6B
Expense Ratio
-
Dividend Yield
3.18%
Beta
0.88
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.55% | +2.41% | +6.51% | +19.82% | +17.29% | +9.09% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.16% |
| 2 | HSBA.L | HSBC Holdings PLC | 1.11% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.02% |
| 4 | AZN.L | AstraZeneca PLC | 0.97% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 0.96% |
| 6 | RY | Royal Bank of Canada | 0.92% |
| 7 | NESN.SW | Nestle SA | 0.90% |
| 8 | SHEL.L | Shell PLC | 0.81% |
| 9 | SIE.DE | Siemens AG | 0.81% |
| 10 | BHP.AX | BHP Group Ltd | 0.78% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is free float adjusted, market cap weighted, and is designed to measure large-, mid- and small-capitalization equity market performance and includes stocks from North America, Europe, Australasia and the Far East.
Inception Date: 2017-03-21